Cargando...
Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
BACKGROUND AND AIMS: Anti‐Tumor Necrosis Factor (TNF)‐induced lupus (ATIL) is a distinct clinical entity, increasingly recognized in patients with inflammatory bowel disease treated with anti‐TNF therapy. Our aims were to evaluate the incidence and clinical and serological markers of ATIL in this po...
Gardado en:
| Publicado en: | JGH Open |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7273700/ https://ncbi.nlm.nih.gov/pubmed/32514462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12291 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|